Gunn et al. Grobin, A. C., Heenan, E. J., Lieber- man, J. A., and Morrow, A. L. (2003). Perinatal neurosteroid levels inﬂu- ence GABAergic interneuron local- ization in adult rat prefrontal cortex. J. Neurosci. 23, 1832–1839. Guidotti, A., and Costa, E. (1998). Can the antidysphoric and anxi- olytic proﬁles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α-tetrahydroprogesterone (allo- pregnanolone) availability? Biol. Psychiatry 44, 865–873. Gunn, B. G., Cooper, M. A., Lambert, J. J., and Belelli, D. B. (2010). Neu- rosteroids Potently Enhance Synaptic GABAA Receptor-Mediated Inhibi- tion in Medial Parvocellular Neurons of the Paraventricular Nucleus of the Mouse Hypothalamus. Program No. 338.26. 2010. Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience. Haage, D., Druzin, M., and Johansson, S. (2002). Allopregnanolone modu- lates spontaneous GABA release via presynaptic Cl- permeability in rat preoptic nerve terminals. Brain Res. 958, 405–413. Han, S. K., Chong, W., Li, L. H., Lee, I. S., Murase, K., and Ryu, P. D. (2002). Noradrenaline excites and inhibits GABAergic transmission in parvocellular neurons of rat hypo- thalamic paraventricular nucleus. J. Neurophysiol. 87, 2287–2296. Harney, S. C., Frenguelli, B. G., and Lambert, J. J. (2003). Phosphoryla- tion inﬂuences neurosteroid mod- ulation of synaptic GABAA recep- tors in rat CA1 and dentate gyrus neurones. Neuropharmacology 45, 873–883. Harrison, N. L., and Simmonds, M. A. (1984). Modulation of the GABA receptor complex by a steroid anaes- thetic. Brain Res. 323, 287–292. Harrison, N. L., Vicini, S., and Barker, J. L. (1987). A steroid anesthetic pro- longs inhibitory postsynaptic cur- rents in cultured rat hippocampal neurons. J. Neurosci. 7, 604–609. Heilig, M., and Koob, G. F. (2007). A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 30, 399–406. Herd, M. B., Belelli, D., and Lambert, J. J. (2007). Neurosteroid modula- tion of synaptic and extrasynaptic GABAA receptors. Pharmacol. Ther. 116, 20–34. Herman, J. P., and Cullinan, W. E. (1997). Neurocircuitry of stress: cen- tral control of the hypothalamo- pituitary-adrenocortical axis. Trends Neurosci. 20, 78–84. Herman, J. P., Cullinan, W. E., Ziegler, D. R., and Tasker, J. G. (2002). Role of the paraventricular nucleus microenvironment in stress integra- tion. Eur. J. Neurosci. 16, 381–385. Herman, J. P., Figueiredo, H., Mueller, N. K., Ulrich-Lai, Y., Ostrander, M. M., Choi, D. C., and Cullinan, W. E. (2003). Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo- pituitary-adrenocortical responsive- ness. Front. Neuroendocrinol. 24, 151–180. Hewitt, S. A., Wamsteeker, J. I., Kurz, E. U., and Bains, J. S. (2009). Altered chloride homeosta- sis removes synaptic inhibitory con- straint of the stress axis. Nat. Neu- rosci. 12, 438–443. Hirst, J. J., Walker, D. W., Yawno, T., and Palliser, H. K. (2009). Stress in preg- nancy: a role for neuroactive steroids in protecting the fetal and neonatal brain. Dev. Neurosci. 31, 363–377. Hodge, C. W., Mehmert, K. K., Kel- ley, S. P., McMahon, T., Haywood, A., Olive, M. F., Wang, D., Sanchez- Perez, A. M., and Messing, R. O. (1999). Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCε. Nat. Neurosci. 2, 997–1002. Holsboer, F. (2000). The corticos- teroid receptor hypothesis of depres- sion. Neuropsychopharmacology 23, 477–501. Hosie, A. M., Clarke, L., da Silva, H., and Smart, T. G. (2009). Conserved site for neurosteroid modulation of GABAA receptors. Neuropharmacol- ogy 56, 149–154. Hosie, A. M., Wilkins, M. E., da Silva, H. M., and Smart, T. G. (2006). Endogenous neurosteroids regulate GABAA receptors through two dis- crete transmembrane sites. Nature 444, 486–489. Imaki, T., Nahan, J. L., Rivier, C., Sawchenko, P. E., and Vale, W. (1991). Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glu- cocorticoids and stress. J. Neurosci. 11, 585–599. Izumi, Y., Murayama, K., Tokuda, K., Krishnan, K., Covey, D. F., and Zorumski, C. F. (2007). GABAer- gic neurosteroids mediate the effects of ethanol on long-term potentia- tion in rat hippocampal slices. Eur. J. Neurosci. 26, 1881–1888. Izumi, Y., Tokuda, K., and Zorum- ski, C. F. (2008). Long-term poten- tiation inhibition by low-level N - methyl-d-aspartate receptor acti- vation involves calcineurin, nitric oxide, and p38 mitogen-activated protein kinase. Hippocampus 18, 258–265. Joels, M., Karst, H., Krugers, H. J., and Lucassen, P. J. (2007). Chronic stress: implications for neuronal morphology, function and neuro- genesis. Front. Neuroendocrinol. 28, 72–96. Karavolas, H. J., and Hodges, D. R. (1990). Neuroendocrine metabo- lism of progesterone and related progestins. Ciba Found. Symp. 153, 22–44. Karst, H., Berger, S., Erdmann, G., Schutz, G., and Joels, M. (2010). Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc. Natl. Acad. Sci. U.S.A. 107, 14449–14454. Karst, H., Berger, S., Turiault, M., Tronche, F., Schutz, G., and Joels, M. (2005). Mineralocorticoid recep- tors are indispensable for nonge- nomic modulation of hippocampal glutamate transmission by corticos- terone. Proc. Natl. Acad. Sci. U.S.A. 102, 19204–19207. Kehoe, P., Mallinson, K., McCormick, C. M., and Frye, C. A. (2000). Central allopregnanolone is increased in rat pups in response to repeated, short episodes of neonatal isolation. Brain Res. Dev. Brain Res. 124, 133–136. Keller, E. A., Zamparini, A., Borodinsky, L. N., Gravielle, M. C., and Fisz- man, M. L. (2004). Role of allopreg- nanolone on cerebellar granule cells neurogenesis. Brain Res. Dev. Brain Res. 153, 13–17. Khisti, R. T., Boyd, K. N., Kumar, S., and Morrow, A. L. (2005). Sys- temic ethanol administration ele- vates deoxycorticosterone levels and chronic ethanol exposure attenu- ates this response. Brain Res. 1049, 104–111. Khisti, R. T.,VanDoren, M. J., O’Buckley, T., and Morrow, A. L. (2003). Neuroactive steroid 3α-hydroxy-5α- pregnan-20-one modulates ethanol- induced loss of righting reﬂex in rats. Brain Res. 980, 255–265. Kittler, J. T., and Moss, S. J. (2003). Mod- ulation of GABAA receptor activ- ity by phosphorylation and recep- tor trafﬁcking: implications for the efﬁcacy of synaptic inhibition. Curr. Opin. Neurobiol. 13, 341–347. Koksma, J. J., Van Kesteren, R. E., Rosahl, T. W., Zwart, R., Smit, A. B., Luddens, H., and Brussaard, A. B. (2003). Oxytocin regulates neuros- teroid modulation of GABAA recep- tors in supraoptic nucleus around parturition. J. Neurosci. 23, 788–797. Koob, G., and Kreek, M. J. (2007). Stress, dysregulation of drug reward path- ways, and the transition to drug dependence. Am. J. Psychiatry 164, 1149–1159. Koob, G. F. (2008). A role for brain stress systems in addiction. Neuron 59, 11–34. Koob, G. F., and Le Moal, M. (2001). Drug addiction, dysregulation of GABAA receptors, neurosteroids, and stress reward, and allostasis. Neuropsy- chopharmacology 24, 97–129. Koob, G. F., and Zorrilla, E. P. (2010). Neurobiological mechanisms of addiction: focus on corticotropin- releasing factor. Curr. Opin. Investig. Drugs 11, 63–71. Korosi, A., Shanabrough, M., McClel- land, S., Liu, Z. W., Borok, E., Gao, X. B., Horvath, T. L., and Baram, T. Z. (2010). Early-life expe- rience reduces excitation to stress- responsive hypothalamic neurons and reprograms the expression of corticotropin-releasing hormone. J. Neurosci. 30, 703–713. Kullmann, D. M., Ruiz, A., Rusakov, D. M., Scott, R., Semyanov, A., and Walker, M. C. (2005). Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog. Biophys. Mol. Biol. 87, 33–46. Lambert, J. J., Belelli, D., Hill-Venning, C., and Peters, J. A. (1995). Neuros- teroids and GABAA receptor func- tion. Trends Pharmacol. Sci. 16, 295–303. Lambert, J. J., Cooper, M. A., Simmons, R. D., Weir, C. J., and Belelli, D. (2009). Neurosteroids: endogenous allosteric modulators of GABAA receptors. Psychoneuroendocrinology 34(Suppl. 1), S48–S58. Lambert, J. J., Peters, J. A., and Cot- trell, G. A. (1987). Actions of syn- thetic and endogenous steroids on the GABAA receptor. Trends Phar- macol. Sci. 8, 224–227. Levitt, N. S., Lambert, E. V., Woods, D., Hales, C. N., Andrew, R., and Seckl, J. R. (2000). Impaired glu- cose tolerance and elevated blood pressure in low birth weight, non obese, young south african adults: early programming of cortisol axis. J. Clin. Endocrinol. Metab. 85, 4611–4618. Li, X., Bertics, P. J., and Karavolas, H. J. (1997). Regional distrib- ution of cytosolic and partic- ulate 5α-dihydroprogesterone 3α- hydroxysteroid oxidoreductases in female rat brain. J. Steroid Biochem. Mol. Biol. 60, 311–318. Liston, C., Miller, M. M., Goldwater, D. S., Radley, J. J., Rocher, A. B., Hof, P. R., Morrison, J. H., and McEwen, B. S. (2006). Stress-induced alter- ations in prefrontal cortical den- dritic morphology predict selective impairments in perceptual atten- tional set-shifting. J. Neurosci. 26, 7870–7874. Longone, P., Rupprecht, R., Manieri, G. A., Bernardi, G., Romeo, E., and Pasini, A. (2008). The complex roles of neurosteroids in depression and anxiety disorders. Neurochem. Int. 52, 596–601. Frontiers in Neuroscience | Neuroendocrine Science December 2011 | Volume 5 | Article 131 | 16